Human Immune Responses to Viral Gene Therapy Vectors

Learning Objectives:

• describe the basics of in vivo gene therapy and define the challenges to successful gene transfer in humans posed by vector-driven immune responses.
• illustrate the mechanisms driving vector related immunogenicity and immune related toxicities observed in gene therapy trials.
• summarize the strategies to address vector immunogenicity from vector design, manufacturing, to pharmacological immunomodulation.